摘要
<正>Tamoxifen (TAM) has been one of the most widely applied endocrine drugs for the treatment of ER positive breast cancer.Unfortunately,clinical resistance to tamoxifen is frequent and precedes death from metastases.In our recent study,we found that Nrf2 showed higher expression in MCF-7 tamoxifen resistant cells(MCF-7/TR)than in MCF-7 parental cells(MCF-7/P),so as other anti-oxidant genes,such as SOD1,ME1,HO1,GPX2 and so on.All these higher expression genes led to
引文